Viktor Umansky
Impact in
- Immunology top 0.1%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
- Immunology 99
- Immune cells in cancer 61
- Immunotherapy and Immune Responses 30
- T-cell and B-cell Immunology 11
- Oncology 58
- Cancer Immunotherapy and Biomarkers 40
- Cancer Cells and Metastasis 13
- Co-authors
- Jochen Sven Utikal (72 shared papers)Peter Altevogt (26 shared papers)Alexandra Sevko (19 shared papers)Rebekka Weber (15 shared papers)Christopher Groth (15 shared papers)Xiaoying Hu (10 shared papers)Viktor Fleming (6 shared papers)Christoffer Gebhardt (18 shared papers)
- Journals
- International Journal of Cancer (14 papers)Cancer Immunology Immunotherapy (14 papers)OncoImmunology (14 papers)Journal for ImmunoTherapy of Cancer (8 papers)Cancers (7 papers)
- Partner nations
- GermanyUnited StatesIsrael
In The Last Decade
Viktor Umansky
166 papers receiving 15.2k citations
Viktor Umansky's Hit Papers
Peers
Comparison fields: 5 of 104
- Immunology 6.3k
- Oncology 4.9k
- Hepatology 816
- Cancer Research 660
- Genetics 344
Countries citing papers authored by Viktor Umansky
This map shows the geographic impact of Viktor Umansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viktor Umansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viktor Umansky more than expected).
Fields of papers citing papers by Viktor Umansky
This network shows the impact of papers produced by Viktor Umansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viktor Umansky. The network helps show where Viktor Umansky may publish in the future.
Co-authors
The 25 scholars most cited alongside Viktor Umansky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 167 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards Hit paper breakdown → | 2016 | 2318 |
| 2 | NASH limits anti-tumour surveillance in immunotherapy-treated HCC Hit paper breakdown → | 2021 | 1029 |
| 3 | Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression Hit paper breakdown → | 2018 | 695 |
| 4 | 2018 | 455 | |
| 5 | 2018 | 391 | |
| 6 | 2012 | 365 | |
| 7 | 2016 | 358 | |
| 8 | Myeloid-derived suppressor cells in cancer and cancer therapy Hit paper breakdown → | 2024 | 327 |
| 9 | 2015 | 320 | |
| 10 | 2011 | 308 | |
| 11 | 2009 | 298 | |
| 12 | 2019 | 289 | |
| 13 | 2003 | 286 | |
| 14 | 2014 | 255 | |
| 15 | 2015 | 255 | |
| 16 | 2020 | 254 | |
| 17 | 2018 | 222 | |
| 18 | 2013 | 217 | |
| 19 | 2013 | 213 | |
| 20 | 2019 | 184 |
About Viktor Umansky
Viktor Umansky is a scholar working on Immunology, Oncology, Molecular Biology, Physiology and Hematology, having authored 167 papers that have together received 15.4k indexed citations. Recurring topics across this work include Immune cells in cancer (61 papers), Cancer Immunotherapy and Biomarkers (40 papers), Immunotherapy and Immune Responses (30 papers), Melanoma and MAPK Pathways (15 papers), Cancer Cells and Metastasis (13 papers), T-cell and B-cell Immunology (11 papers), Extracellular vesicles in disease (7 papers) and Adenosine and Purinergic Signaling (4 papers). The work is most often cited by research in Immunology (6.3k citations), Oncology (4.9k citations), Hepatology (816 citations), Cancer Research (660 citations) and Genetics (344 citations). Viktor Umansky has collaborated with scholars based in Germany, United States and Israel. Frequent co-authors include Jochen Sven Utikal, Peter Altevogt, Alexandra Sevko, Rebekka Weber, Christopher Groth, Xiaoying Hu, Viktor Fleming, Christoffer Gebhardt, Philipp Beckhove and Sven Brandau. Their work appears in journals such as International Journal of Cancer, Cancer Immunology Immunotherapy, OncoImmunology, Journal for ImmunoTherapy of Cancer and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.